Investment Rating - The report assigns a "Buy-A" investment rating to the company with a 12-month target price of 63 yuan [3][6]. Core Insights - The company achieved a revenue of 775 million yuan in the first three quarters of 2025, reflecting a year-on-year increase of 1.49%. However, the net profit attributable to shareholders decreased by 4.21% to 143 million yuan [1]. - In Q3 2025, the company reported a revenue of 358 million yuan, marking a significant year-on-year growth of 26.89% and a quarter-on-quarter increase of 22.19%. The net profit for the same quarter was 66 million yuan, down 5.39% year-on-year but up 35.99% quarter-on-quarter [1]. - The company is continuously increasing its R&D investment, with R&D expenses in Q3 2025 amounting to 25 million yuan, a year-on-year increase of 6.6% [1][2]. Financial Performance Summary - The company's gross margin for the first three quarters of 2025 was 37.41%, a slight increase of 0.16 percentage points year-on-year, while the net profit margin was 18.57%, down 1.82 percentage points year-on-year [1]. - The report forecasts net profits for 2025, 2026, and 2027 to be 214 million, 264 million, and 334 million yuan respectively, with growth rates of 7.5%, 23.5%, and 26.6% [3][9]. - The company has seen a significant increase in contract liabilities, which rose by 208.81% compared to the beginning of the period [1]. Production Capacity and Efficiency - The company is optimizing and upgrading its production capacity for power modules, aiming for an increase of over 20% in capacity to meet the demands of ongoing projects [2].

Investment Rating - The report assigns a "Buy-A" investment rating to the company with a 12-month target price of 68.16 CNY [5][7]. Core Views - The company experienced a revenue decline of 13.37% year-on-year in H1 2025, with total revenue reaching 417 million CNY. However, the net profit attributable to shareholders decreased only by 3.18% to 77 million CNY, indicating resilience in profitability despite revenue challenges [1][2]. - The company is actively enhancing its production capacity and optimizing its operations, particularly in the ammunition equipment sector, which saw a revenue increase of 2.75% year-on-year [4]. - Research and development investments are being prioritized, with a total expected investment of 517 million CNY in ongoing projects, reflecting the company's commitment to innovation and future growth [3]. Summary by Sections Financial Performance - In H1 2025, the company's military product revenue was 396 million CNY, down 13.92% year-on-year, while civilian product revenue increased by 3.75% to 20 million CNY. The overall gross margin improved to 38.41%, up 2.25 percentage points year-on-year, and the net profit margin rose to 18.52%, an increase of 1.27 percentage points [2]. Research and Development - The company increased its R&D expenses by 29.21% to 55 million CNY, indicating a strong focus on innovation. The total investment in R&D projects is projected to reach 517 million CNY, with 394 million CNY already invested [3]. Production Capacity - The ammunition equipment business generated 170 million CNY in revenue, with a notable performance from the subsidiary, which achieved a 22.03% increase in revenue. The company is also optimizing its production lines to enhance capacity by over 20% [4]. Future Projections - The company is projected to achieve net profits of 241 million CNY, 297 million CNY, and 356 million CNY for the years 2025, 2026, and 2027, respectively, with growth rates of 21.3%, 23.1%, and 19.9% [5][6].